Shenzhen HarMoniCare Women&Children's Hospital, affiliated with HarMoniCare Medical Holding Limited, is the largest private maternity hospital in China. On July 7,2015, the corporation was officially registered on the Hong Kong Stock Exchange (Hong Kong stock code 01509). Shenzhen HarMoniCare Women&Children's Hospital provides high-quality health care and health management services for women and children from China and abroad.
In October,2011, HarMoniCare passed the initial accreditation survey by Joint Commission International(JCI), becoming the first JCI-accredited hospital in Shenzhen. In October,2014,HarMoniCare Shenzhen Women and Children's Hospital again sailed through the second accreditation survey besed on the newly-published fifth edition edition JCI standards with flying colors，In November 15, 2017, HarMoniCare Shenzhen Women and Children's hospital were successfully reexamined by the new JCI Sixth Edition.
HarMoniCare Shenzhen Women and Children's Hospital adopts and advocates an American patient safety and care system, which is the world's leading model of medical technology and management, providing safe and green care for customers. HarMoniCare advocates treatment with topically-applied medication and physiotherapy treatment office disease, and improvement of patients' sub-health status and noncommunicable diseases through behavioral medical intervention. HarMoniCare strictly follows recommendations for the appropriate prescription of antibiotics and is committed to reducing overtreatment.